icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018		 Back grey_arrow_rt.gif
 
 
 
Early adoption of tenofovir alafenamide (TAF) for Hepatitis B
in US clinical practice; real-world evidence from the TRIO network
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF

1211181

1211182

1211183

1211184

1211185